Avanza Fonder AB Has $2.05 Million Holdings in Tempus AI, Inc. (NASDAQ:TEM)

Avanza Fonder AB lifted its stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 15.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 41,005 shares of the company's stock after buying an additional 5,591 shares during the period. Avanza Fonder AB's holdings in Tempus AI were worth $2,047,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Victory Capital Management Inc. bought a new position in Tempus AI during the fourth quarter worth about $216,000. Wells Fargo & Company MN raised its position in Tempus AI by 13.2% in the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock worth $80,000 after purchasing an additional 278 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new position in Tempus AI in the 4th quarter worth approximately $178,000. SeaCrest Wealth Management LLC bought a new position in Tempus AI in the 1st quarter worth approximately $535,000. Finally, ProShare Advisors LLC bought a new position in Tempus AI in the 4th quarter worth approximately $244,000. Institutional investors own 24.22% of the company's stock.

Insider Activity

In other Tempus AI news, CFO James William Rogers sold 23,030 shares of the stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $45.97, for a total value of $1,058,689.10. Following the transaction, the chief financial officer now directly owns 164,750 shares of the company's stock, valued at $7,573,557.50. This represents a 12.26% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Wayne A.I. Frederick sold 3,000 shares of the stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $45.54, for a total transaction of $136,620.00. Following the completion of the transaction, the director now directly owns 26,514 shares in the company, valued at approximately $1,207,447.56. This represents a 10.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 345,735 shares of company stock valued at $21,865,719. 27.60% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research firms recently weighed in on TEM. Morgan Stanley boosted their price objective on shares of Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Guggenheim reiterated a "buy" rating on shares of Tempus AI in a research report on Tuesday, February 25th. William Blair reissued a "market perform" rating on shares of Tempus AI in a report on Tuesday, February 25th. Wolfe Research lowered shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 26th. Finally, JPMorgan Chase & Co. lowered shares of Tempus AI from an "overweight" rating to a "neutral" rating and boosted their price target for the company from $50.00 to $55.00 in a report on Tuesday, February 25th. Six investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $63.42.

Tempus AI Stock Down 0.0%

NASDAQ:TEM traded down $0.01 on Friday, hitting $71.22. 12,804,122 shares of the company's stock were exchanged, compared to its average volume of 7,004,840. The firm has a 50-day moving average price of $55.90 and a 200-day moving average price of $52.31. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $91.45. The company has a market cap of $12.33 billion and a P/E ratio of -9.13.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.27) by $0.03. The business had revenue of $255.74 million for the quarter, compared to the consensus estimate of $248.13 million. Tempus AI's revenue was up 75.4% on a year-over-year basis. As a group, analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.